BioLineRx (BLRX) Receivables (2010 - 2025)
BioLineRx's (BLRX) quarterly Receivables came in at $456000.0 in Q4 2025, down 88.47% year-on-year from $4.0 million in Q4 2024, and up 62.28% quarter-over-quarter from $281000.0 in Q2 2025.
BioLineRx (BLRX) Receivables (2010 - 2025) Analysis & Trends
BioLineRx's Receivables history runs 6 years deep, the most recent figure standing at $456000.0 for Q4 2025.
- On a quarterly basis, Receivables fell 88.47% year-over-year to $456000.0 in Q4 2025; TTM through Dec 2025 was $456000.0, a 88.47% decrease from a year earlier, with the FY2025 full-year figure at $456000.0, down 88.47% from the prior year.
- Receivables rose to $456000.0 in Q4 2025 per BLRX's latest filing, from $281000.0 in the prior quarter.
- Across five years, Receivables topped out at $4.0 million in Q3 2024 and bottomed at $281000.0 in Q2 2025.
- The 4-year median for Receivables is $1.9 million (2025), against an average of $2.2 million.
- Across the five-year window, Receivables jumped 232.83% in 2024 and plunged 92.67% in 2025, its largest moves.
- Year by year, Receivables stood at $721000.0 in 2022, then jumped by 64.77% to $1.2 million in 2023, then soared by 232.83% to $4.0 million in 2024, then plunged by 88.47% to $456000.0 in 2025.
- Per Business Quant, the three latest BLRX Receivables figures stand at $456000.0 (Q4 2025), $281000.0 (Q2 2025), and $1.9 million (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | BioLineRx | 7.05 Bn | 7.06 Bn | 154,000.00 | 456,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 456,000.00 |
| Jun 30, 2025 | 281,000.00 |
| Mar 31, 2025 | 1.92 Mn |
| Dec 31, 2024 | 3.95 Mn |
| Sep 30, 2024 | 3.96 Mn |
| Jun 30, 2024 | 3.84 Mn |
| Mar 31, 2024 | 3.34 Mn |
| Dec 31, 2023 | 1.19 Mn |
| Dec 31, 2022 | 721,000.00 |
| Jun 30, 2011 | 5.09 Mn |
| Dec 31, 2010 | 10.59 Mn |